What's in AVM Biotechnology Inc's pipeline?

AVM Biotechnology Inc has 2 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 1 in Phase 2, 0 in Phase 1.

Which companies overlap with AVM Biotechnology Inc's portfolio?

Top competitors by shared drug class: Bayer, GBG Forschungs GmbH, HK inno.N Corporation, IBSA Institut Biochimique SA, Jason Lang, M.D., M.P.H..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/avm-biotechnology-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

AVM Biotechnology Inc — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

AVM Biotechnology Inc pipeline: 1 marketed, 0 filed, 0 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Proton pump inhibitor	Proton pump inhibitor	marketed	Proton pump inhibitor	H+/K+-ATPase (proton pump)	Gastroenterology

Therapeutic area mix

Gastroenterology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Bayer · 1 shared drug class
GBG Forschungs GmbH · 1 shared drug class
HK inno.N Corporation · 1 shared drug class
IBSA Institut Biochimique SA · 1 shared drug class
Jason Lang, M.D., M.P.H. · 1 shared drug class
Jun-Won Chung · 1 shared drug class
Merck Sharp & Dohme LLC · 1 shared drug class
Samsung Medical Center · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for AVM Biotechnology Inc:

Cite this brief

Drug Landscape (2026). AVM Biotechnology Inc — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/avm-biotechnology-inc. Accessed 2026-05-17.